Business ❯ Finance ❯ Investments ❯ Securities

Stock Market

MoonLake Investors Face Dec. 15 Lead-Plaintiff Deadline in SDNY Securities Case

Investors have until December 15, 2025 to seek lead-plaintiff status in the SDNY case alleging misstatements about sonelokimab's touted Nanobody advantages.

Stories older than 24h

5 ARTICLES

last wk.

Nov. 10 Lead Plaintiff Deadline Set in Lantheus Pylarify Securities Suits

4 ARTICLES

2w ago

SelectQuote Investor Suit Nears Oct. 10 Lead-Plaintiff Deadline

6 ARTICLES

4w ago

Sept. 30 Lead‑Plaintiff Deadline Nears in Novo Nordisk Securities Case